Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sachin J Shah

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of the American College of Cardiology|July 17, 2024
Anticoagulants in Subclinical Atrial Fibrillation: Beginning to Define the Treatment ParadigmSachin J Shah
NEJM Evidence|May 26, 2026
Beyond Equal Weighting - A Step Toward Incorporating Patient Preferences in Atrial Fibrillation TrialsSachin J Shah
Journal of Hospital Medicine|June 29, 2019
Restarting Anticoagulants after a Gastrointestinal Hemorrhage-Between Rockall and a Hard PlaceSachin J Shah, Mark H Eckman
JAMA Internal Medicine|March 7, 2022
Follow-up Duration and Gender Differences in a Study of Older Adults Living Alone-ReplySachin J Shah, Kenneth E Covinsky
Annals of Internal Medicine|June 4, 2019
Stroke Rate Variation and Anticoagulation Benefit in Atrial FibrillationSachin J Shah, Daniel E Singer
NEJM Evidence|February 6, 2024
Do Anticoagulants Preserve Function and Quality of Life in Older Adults with Atrial Fibrillation?Sachin J Shah, Kenneth E Covinsky
Circulation. Cardiovascular Quality and Outcomes|April 14, 2022
Equitable Representation in Clinical Trials: Looking Beyond Table 1Sachin J Shah, Utibe R Essien
The Journal of Emergency Medicine|March 30, 2010
A screening tool to medically clear psychiatric patients in the emergency departmentSachin J Shah, Michael Fiorito, Robert M McNamara
American Heart Journal|February 16, 2010
ST-elevation myocardial infarction patients can be enrolled in randomized trials before emergent coronary intervention without sacrificing door-to-balloon timeAditya Mandawat, Sachin J Shah, Saif S Rathore
JAMA|March 15, 2024
Use of Lecanemab for Patients With Cardiovascular Disease: The Challenge of UncertaintyDarae Ko, Alvaro Pascual-Leone, Sachin J Shah
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of the American College of Cardiology|July 17, 2024
Anticoagulants in Subclinical Atrial Fibrillation: Beginning to Define the Treatment ParadigmSachin J Shah
NEJM Evidence|May 26, 2026
Beyond Equal Weighting - A Step Toward Incorporating Patient Preferences in Atrial Fibrillation TrialsSachin J Shah
Journal of Hospital Medicine|June 29, 2019
Restarting Anticoagulants after a Gastrointestinal Hemorrhage-Between Rockall and a Hard PlaceSachin J Shah, Mark H Eckman
JAMA Internal Medicine|March 7, 2022
Follow-up Duration and Gender Differences in a Study of Older Adults Living Alone-ReplySachin J Shah, Kenneth E Covinsky
Annals of Internal Medicine|June 4, 2019
Stroke Rate Variation and Anticoagulation Benefit in Atrial FibrillationSachin J Shah, Daniel E Singer
NEJM Evidence|February 6, 2024
Do Anticoagulants Preserve Function and Quality of Life in Older Adults with Atrial Fibrillation?Sachin J Shah, Kenneth E Covinsky
Circulation. Cardiovascular Quality and Outcomes|April 14, 2022
Equitable Representation in Clinical Trials: Looking Beyond Table 1Sachin J Shah, Utibe R Essien
The Journal of Emergency Medicine|March 30, 2010
A screening tool to medically clear psychiatric patients in the emergency departmentSachin J Shah, Michael Fiorito, Robert M McNamara
American Heart Journal|February 16, 2010
ST-elevation myocardial infarction patients can be enrolled in randomized trials before emergent coronary intervention without sacrificing door-to-balloon timeAditya Mandawat, Sachin J Shah, Saif S Rathore
JAMA|March 15, 2024
Use of Lecanemab for Patients With Cardiovascular Disease: The Challenge of UncertaintyDarae Ko, Alvaro Pascual-Leone, Sachin J Shah
Pageof 8